Company profile ATXI

Avenue Therapeutics Inc
avenue therapeutics, inc. (nasdaq: atxi), a fortress biotech (nasdaq: fbio) company, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (iv) tramadol for the management of moderate to moderately severe postoperative pain. iv tramadol may fill a gap in the acute pain market between iv acetaminophen/nsaids and iv conventional nar...cotics. avenue is currently evaluating iv tramadol in a pivotal phase 3 program for the management of postoperative pain. Show More
Quarter analysis & expected interestLast update: February 08 2024 15:39:39.

After 39 days of this quarter the interest is at 77.0. Based on that we can calculate that during remaining 52 days it will total up to 180.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019157
98
-37.6% QoQ
129
31.6% QoQ
144
11.6% QoQ
2020 180
14.6% YoY 25.0% QoQ
126
28.6% YoY -30.0% QoQ
92
-28.7% YoY -27.0% QoQ
210
45.8% YoY 128.3% QoQ
2021 193
7.2% YoY -8.1% QoQ
345
173.8% YoY 78.8% QoQ
169
83.7% YoY -51.0% QoQ
117
-44.3% YoY -30.8% QoQ
2022 268
38.9% YoY 129.1% QoQ
157
-54.5% YoY -41.4% QoQ
164
-3.0% YoY 4.5% QoQ
181
54.7% YoY 10.4% QoQ
2023 176
-34.3% YoY -2.8% QoQ
115
-26.8% YoY -34.7% QoQ
136
-17.1% YoY 18.3% QoQ
149
-17.7% YoY 9.6% QoQ
2024 77
-56.2% YoY -48.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Avenue Therapeutics search interestLast update: February 08 2024 15:39:37.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 15:39:40.

The average 5 years interest of Avenue Therapeutics was 12.96 per week.
The last year interest of Avenue Therapeutics compared to the last 5 years has changed by -16.74%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -7.38%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 15:39:45.

After 39 days of this quarter the interest is at 26.0. Based on that we can calculate that during remaining 52 days it will total up to 61.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
201911
0
-100.0% QoQ
67
inf% QoQ
76
13.4% QoQ
2020 51
363.6% YoY -32.9% QoQ
0
363.6% YoY -100.0% QoQ
48
-28.4% YoY inf% QoQ
86
13.2% YoY 79.2% QoQ
2021 50
-2.0% YoY -41.9% QoQ
179
inf% YoY 258.0% QoQ
111
131.2% YoY -38.0% QoQ
16
-81.4% YoY -85.6% QoQ
2022 16
-68.0% YoY 0.0% QoQ
35
-80.4% YoY 118.8% QoQ
21
-81.1% YoY -40.0% QoQ
39
143.8% YoY 85.7% QoQ
2023 70
337.5% YoY 79.5% QoQ
61
74.3% YoY -12.9% QoQ
115
447.6% YoY 88.5% QoQ
73
87.2% YoY -36.5% QoQ
2024 26
-62.9% YoY -64.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Avenue Therapeutics stock search interestLast update: February 08 2024 15:39:45.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 15:39:47.

The average 5 years interest of Avenue Therapeutics stock was 4.41 per week.
The last year interest of Avenue Therapeutics stock compared to the last 5 years has changed by 28.57%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 91.55%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for AJ201 clinical trial to provide analysis

Correlation between past revenue and AJ201 clinical trial search interest

There is not enough data for AJ201 clinical trial to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for AJ201 clinical trial to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Intravenous Tramadol to provide analysis

Correlation between past revenue and Intravenous Tramadol search interest

There is not enough data for Intravenous Tramadol to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Intravenous Tramadol to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BAER-101 epilepsy to provide analysis

Correlation between past revenue and BAER-101 epilepsy search interest

There is not enough data for BAER-101 epilepsy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BAER-101 epilepsy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BAER-101 panic disorders to provide analysis

Correlation between past revenue and BAER-101 panic disorders search interest

There is not enough data for BAER-101 panic disorders to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BAER-101 panic disorders to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Avenue Therapeutics jobs to provide analysis

Correlation between past revenue and Avenue Therapeutics jobs search interest

There is not enough data for Avenue Therapeutics jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Avenue Therapeutics jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Avenue Therapeutics reviews to provide analysis

Correlation between past revenue and Avenue Therapeutics reviews search interest

There is not enough data for Avenue Therapeutics reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Avenue Therapeutics reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Avenue Therapeutics Tampa to provide analysis

Correlation between past revenue and Avenue Therapeutics Tampa search interest

There is not enough data for Avenue Therapeutics Tampa to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Avenue Therapeutics Tampa to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 03 2023 20:49:17.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 0
2019 0
0
0
0
2020 0
0
204
inf% YoY inf% QoQ
311
inf% YoY 52.5% QoQ
2021 270
inf% YoY -13.2% QoQ
493
inf% YoY 82.6% QoQ
154
-24.5% YoY -68.8% QoQ
139
-55.3% YoY -9.7% QoQ
2022 156
-42.2% YoY 12.2% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2023 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Avenue Therapeutics -stock -company search interestLast update: November 03 2023 20:49:17.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 03 2023 20:49:18.

The average 5 years interest of Avenue Therapeutics -stock -company was 6.62 per week.
The last year interest of Avenue Therapeutics -stock -company compared to the last 5 years has changed by -100.0%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ATXI
Earnings date: 2024-02-29 Before open
Company name: Avenue Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-05-15T16:07:15-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

2025-04-30T16:30:25-04:00

SEC
8-K Form - Current report, items 1.01, 1.02, 2.01, and 9.01 - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

2025-04-02T17:00:06-04:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - AVENUE THERAPEUTICS, INC. (0001644963) (Subject)

2025-04-02T16:05:13-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - AVENUE THERAPEUTICS, INC. (0001644963) (Issuer)

2025-03-31T16:16:02-04:00

SEC
10-K Form - Annual report [Section 13 and 15(d), not S-K Item 405] - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

2025-03-17T17:20:03-04:00

SEC
8-K Form - Current report, item 3.01 - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

2025-03-07T16:30:20-05:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

2025-02-14T17:01:00-05:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - AVENUE THERAPEUTICS, INC. (0001644963) (Subject)

2025-02-14T13:25:08-05:00

SEC
SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - AVENUE THERAPEUTICS, INC. (0001644963) (Subject)

2024-11-15T16:05:50-05:00

SEC
SC 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - AVENUE THERAPEUTICS, INC. (0001644963) (Subject)

2024-11-14T16:15:45-05:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

2024-11-14T16:10:16-05:00

SEC
8-K Form - Current report, items 2.02 and 9.01 - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

2024-11-14T21:05:03Z

GlobeNewswire
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

2024-11-14T15:22:45-05:00

SEC
SC 13G Form - Statement of Beneficial Ownership by Certain Investors - AVENUE THERAPEUTICS, INC. (0001644963) (Subject)

2024-11-07T19:12:00-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - AVENUE THERAPEUTICS, INC. (0001644963) (Issuer)